(Q57384005)

7

0 references

Michael Höfler

4

object named as

Michael Höfler

0 references

author name string

David Pittrow

2

0 references

Hendrik Lehnert

3

0 references

Wilhelm Kirch

5

0 references

Eberhard Ritz

European Journal of Cardiovascular Prevention and Rehabilitation

6

0 references

publication date

February 2007

0 references

published in

0 references

volume

14

0 references

issue

1

0 references

page(s)

107-113

0 references

cites work

Prevention of diabetic renal disease with special reference to microalbuminuria

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Microalbuminuria in the US population: third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

High prevalence and poor control of hypertension in primary care: cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Prevalence of kidney damage in Australian adults: The AusDiab kidney study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord-Trøndelag Health Study (HUNT, 1995-97), Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Cardiovascular Risk Factors Are Differently Associated with Urinary Albumin Excretion in Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE

[Increased clinical and economic advantages using PROSIT (proteinuria screening and intervention) in type 2 diabetic patients].

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.HJR.0000224489.03221.DE